Tag: CE Mark
August 7, 2019
Nemaura Announces First SugarBEAT Device Shipments
Nemaura Medical (NASDAQ:NMRD) has announced the first shipments of its SugarBEAT devices to diabetic and prediabetic patients in the United... May 29, 2019
Nemaura Receives CE Mark Approval of SugarBEAT
Nemaura Medical (NASDAQ:NMRD) has announced it has received CE Mark approval for SugarBEAT, a non-invasive device for diabetics and pre-diabetics.... June 12, 2018